Please use this identifier to cite or link to this item: 10.15407/ubj90.06.110
Title: The effect of intranasally administered tlr3 agonist larifan on metabolic profile of microglial cells in rat with c6 glioma
Authors: Hurmach, Y.
Rudyk, M.
Svyatetska, V.
Senchylo, N.
Skachkova, O.
Pjanova, D.
Vaivode, K.
Skivka, L.
Keywords: Glioma;Immunotherapy;Microglia;Toll-like receptor agonist;1.6 Biological sciences;3.1 Basic medicine;1.1. Scientific article indexed in Web of Science and/or Scopus database;Biochemistry
Issue Date: 2018
Citation: Hurmach , Y , Rudyk , M , Svyatetska , V , Senchylo , N , Skachkova , O , Pjanova , D , Vaivode , K & Skivka , L 2018 , ' The effect of intranasally administered tlr3 agonist larifan on metabolic profile of microglial cells in rat with c6 glioma ' , Ukrainian Biochemical Journal , vol. 90 , no. 6 , pp. 110-119 . https://doi.org/10.15407/ubj90.06.110
Abstract: Glioma-associated microglia/macrophages (Gam) represent an attractive therapeutic target for the development of the alternative methodology in the treatment of gliomas. This study was aimed to investigate the effect of intranasally administered TLR3 agonist Larifan on microglial cell metabolic profile in rats with C6 glioma. Our results demonstrate progressive generation microglial cell population with immunosuppressive and pro-inflammatory properties in C6 glioma-bearing brain. Intranasally delivered TLR3 agonist is capable to abrogate the creation of this pro-tumoral immune infiltrates, probably, through the effect on myeloid-derived suppressor cells, and can be considered as a promising agent for glioma therapy aimed the Gam re-education.
Description: Publisher Copyright: © 2018 Hurmach Y. et al.
DOI: 10.15407/ubj90.06.110
ISSN: 2409-4943
Appears in Collections:Research outputs from Pure / Zinātniskās darbības rezultāti no ZDIS Pure



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.